Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Long Jiang

3PUBLICATIONS

19CO-AUTHORS

Molecular targetsAutoimmunity

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Mar 16, 2023

The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth <i>In Vivo</i> and Potentiates Radiotherapy.

Katrine Ingelshed, Diana Spiegelberg, Pavitra Kannan

|Nov 09, 2021

CRISPR/Cas9-Induced DNA Damage Enriches for Mutations in a p53-Linked Interactome: Implications for CRISPR-Based Therapies.

Long Jiang, Katrine Ingelshed, Yunbing Shen

|Jan 26, 2020

IL-4 controls activated neutrophil FcγR2b expression and migration into inflamed joints.

Sudeepta Kumar Panda, Gustaf Wigerblad, Long Jiang

Pageof 1

Frequent Collaborators

3 joint publications

Fredrik Wermeling

2 joint publications

Vaishnavi Srinivasan Iyer

2 joint publications

Yunbing Shen

2 joint publications

Zsolt Kasza

2 joint publications

Saikiran Sedimbi

1 joint publications

Sudeepta Kumar Panda

1 joint publications

Gustaf Wigerblad

1 joint publications

Yanek Jiménez-Andrade

1 joint publications

Sanjaykumar V Boddul

1 joint publications

André Ortlieb Guerreiro-Cacais

Frequent Collaborators

3 joint publications

Fredrik Wermeling

2 joint publications

Vaishnavi Srinivasan Iyer

2 joint publications

Yunbing Shen

2 joint publications

Zsolt Kasza

Top Related Videos

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on : May 20, 2019

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on : Aug 25, 2017

<em>In Vivo</em> Imaging Uncovers the Migratory Behavior of Leukocytes within the Joints

<em>In Vivo</em> Imaging Uncovers the Migratory Behavior of Leukocytes within the Joints

Published on : Dec 09, 2025

See more related videos

Top Related Videos

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on : May 20, 2019

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on : Aug 25, 2017

<em>In Vivo</em> Imaging Uncovers the Migratory Behavior of Leukocytes within the Joints

<em>In Vivo</em> Imaging Uncovers the Migratory Behavior of Leukocytes within the Joints

Published on : Dec 09, 2025

See more related videos